(Virtual Event) International Conference on Molecular Imaging and Clinical PET–CT in the Era of Theranostics (IPET-2020) - Programme - Day 3

Thursday, 26 November 2020 #IPET2020

CLINICAL SESSION 6: Neuroendocrine Tumours

Chairperson: Ora Israel, FSNMMI and Israel Institute of Technology - Technion Haifa, Israel

IAEA Coordinator: Francesco Giammarile 

10:00 - 10:20 

Role of CT and MRI in NET - Dietmar Tamandl, ISR

10:20 - 10:50

Theranostics in NET - Irene Virgolini, WARMTH

10:50 - 11:00

Radionuclide therapies in NET: Role of Alpha-emitters - Jolanta Kunikowska, EANM

11:00 - 11:15

Live Q/A

CLINICAL SESSION 7: Thyroid Cancer

Chairperson: Henry Bom, ARCCNM

IAEA Coordinator: Pilar Orellana 

11:15 - 11:30 

Role of Medical Imaging in Thyroid Cancer - Partha Choudhury, WARMTH

11:30 - 11:45

Radionuclide Therapies: Where Are We? - Markus Luster, University of Marburg, Germany

11:45 - 12:00

Case Reviews of Thyroid Cancer - Sabina Dizdarevic, Brighton and Sussex University Hospitals NHS Trust, UK

12:00 - 12:15

Live Q/A

ABSTRACT SESSION 5

12:15 - 12:45

Chairperson: Gopinath Gnanasegaran, Royal Free London NHS Foundation Trust, UK

IAEA Coordinator: Enrique Estrada 

The value of isolated and integrated brain PET and MRI imaging findings to predict treatment response in patients with Alzheimer’s Disease - Tanyaluck Thietunyakit, Thailand (3*)

Evaluation of suspect lung lesions through percutaneous biopsy: differences in diagnostic accuracy between PET/CT and CT - Mateos Bogoni, Brasil (27*)

PET/CT-guided biopsy presents higher malignant positive Results than CT guided biopsy - Mateos Bogoni, Brasil (28*)

*Abstract number

INTERACTIVE SESSION 3: COVID-19

IAEA Coordinator: Diana Paez

12:45 - 13:00

COVID-19: X-ray and US Features - Ivana Blazic, ESR

13:00 - 13:20

COVID-19: CT Features - Marie-Pierre Revel, Paris Descartes University, France

13:20 - 13:35

COVID-19: SPECT and PET Features - Jamshed Bomanji, University College London, UK

CLINICAL SESSION 8: Prostate Cancer

Chairperson: Arturo Chiti, Humanitas Research Hospital - Humanitas University, Italy

IAEA Coordinator: Enrique Estrada 

13:35 - 13:55

What the Clinician Needs to Know - Jochen Walz, Institute Paoli-Calmettes, France

13:55 - 14:15

Role of MRI in Prostate Cancer - Olivier Rouvière, University Hospital Centre of Lyon, France

14:15 - 14:35

Role of PET/CT in the Evaluation of Prostate Cancer - Stefano Fanti, EANM

14:35 - 14:55

Radionuclide Therapies in Prostate Cancer - Mike Sathekge, SNM

14:55 - 15:10

Live Q/A

PLENARY SESSION 3: Future Directions

Chairperson: Stefano Fanti, EANM

IAEA Coordinator: Francesco Giammarile

15:10 - 15:30

PET-CT: Biochemistry of the Living Body - Marcus Hacker, AKH, Austria

15:30 - 15:50

Trends in Medical Imaging - Richard Wahl, SNMMI; Mallinckrodt Institute of Radiology, Washington University in St Louis School of Medicine, USA

CLOSING CEREMONY

IAEA Coordinator: Francesco Giammarile

15:50 - 16:20

Highlight lecture Andrew Scott, Olivia Newton-John Cancer Research Institute, Australia

16:20 - 16:30

Closing remarks Diana Paez, IAEA